Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2024 Filed Mar 18, 2024 20:47 UTC |
Kennard William EDirector
|
GrantCommon Stock | 278 | $71.90 | $19,988.20 |
DisclosureSEC source: 0001099219-24-000087 · wk-form4_1710794833.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,741 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| March 13, 2024 Filed Mar 14, 2024 20:35 UTC |
TADROS RAMYPresident, U.S. Business
|
SaleCommon Stock | 4,026 | $71.90 | $289,479.47 |
DisclosureSEC source: 0001099219-24-000076 · wk-form4_1710448537.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,981 F1 · kind: The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.85 to $72.00, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:36 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 5,164 | $69.73 | $360,085.72 |
DisclosureSEC source: 0001099219-24-000074 · wk-form4_1709674570.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,781 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:36 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
Tax withholdingCommon Stock | 1,907 | $69.73 | $132,975.11 |
DisclosureSEC source: 0001099219-24-000073 · wk-form4_1709674541.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,794 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:35 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 2,741 | $69.73 | $191,129.93 |
DisclosureSEC source: 0001099219-24-000072 · wk-form4_1709674518.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,507 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:35 UTC |
Khalaf MichelDirector · President & CEO
|
Tax withholdingCommon Stock | 16,381 | $69.73 | $1,142,247.13 |
DisclosureSEC source: 0001099219-24-000071 · wk-form4_1709674493.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,587 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:34 UTC |
TADROS RAMYPresident, U.S. Business
|
Tax withholdingCommon Stock | 4,821 | $69.73 | $336,168.33 |
DisclosureSEC source: 0001099219-24-000070 · wk-form4_1709674466.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,007 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:34 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
Tax withholdingCommon Stock | 4,433 | $69.73 | $309,113.09 |
DisclosureSEC source: 0001099219-24-000069 · wk-form4_1709674435.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,768 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:33 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,255 | $69.73 | $87,511.15 |
DisclosureSEC source: 0001099219-24-000068 · wk-form4_1709674380.xml · nonDerivative · entry 1 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,134 F1 · kind: Withheld for taxes on shares issued for restricted stock units. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 21:35 UTC |
Hay Laura JDirector
|
GrantCommon Stock | 237 | $69.16 | $16,390.92 |
DisclosureSEC source: 0001099219-24-000042 · wk-form4_1709156131.xml · nonDerivative · entry 1 Hay Laura J · CIK 0002013372 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 237 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 12,040 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · derivative · entry 4 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,040 Underlying: Common Stock · 12,040 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
Tax withholdingCommon Stock | 13,822 | $69.16 | $955,929.52 |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · nonDerivative · entry 3 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,701 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantCommon Stock | 26,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · nonDerivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,523 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
PODLOGAR SUSAN MEVP & Chief HR Officer
|
GrantCommon Stock | 4,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000057 · wk-form4_1709241686.xml · nonDerivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,555 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantEmployee Stock Options (right to buy) · Derivative | 28,113 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000056 · wk-form4_1709241664.xml · derivative · entry 4 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,113 Underlying: Common Stock · 28,113 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
TADROS RAMYPresident, U.S. Business
|
Tax withholdingCommon Stock | 32,636 | $69.16 | $2,257,105.76 |
DisclosureSEC source: 0001099219-24-000056 · wk-form4_1709241664.xml · nonDerivative · entry 3 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,828 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 62,924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000056 · wk-form4_1709241664.xml · nonDerivative · entry 2 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,464 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
TADROS RAMYPresident, U.S. Business
|
GrantCommon Stock | 9,370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000056 · wk-form4_1709241664.xml · nonDerivative · entry 1 TADROS RAMY · CIK 0001714199 · President, U.S. Business 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,540 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 17,896 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · derivative · entry 4 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,896 Underlying: Common Stock · 17,896 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
Tax withholdingCommon Stock | 16,206 | $69.16 | $1,120,806.96 |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · nonDerivative · entry 3 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,248 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 35,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · nonDerivative · entry 2 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,454 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:21 UTC |
DEBEL MARLENEEVP & Chief Risk Officer
|
GrantCommon Stock | 5,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000055 · wk-form4_1709241645.xml · nonDerivative · entry 1 DEBEL MARLENE · CIK 0001770295 · EVP & Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,497 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 32,538 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000054 · wk-form4_1709241629.xml · derivative · entry 4 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,538 Underlying: Common Stock · 32,538 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
McCallion John D.EVP & Chief Financial Officer
|
Tax withholdingCommon Stock | 34,613 | $69.16 | $2,393,835.08 |
DisclosureSEC source: 0001099219-24-000054 · wk-form4_1709241629.xml · nonDerivative · entry 3 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,945 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 71,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000054 · wk-form4_1709241629.xml · nonDerivative · entry 2 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,558 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
McCallion John D.EVP & Chief Financial Officer
|
GrantCommon Stock | 10,845 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000054 · wk-form4_1709241629.xml · nonDerivative · entry 1 McCallion John D. · CIK 0001709116 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,643 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantEmployee Stock Options (right to buy) · Derivative | 7,593 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000053 · wk-form4_1709241616.xml · derivative · entry 4 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,593 Underlying: Common Stock · 7,593 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 4,251 | $69.16 | $293,999.16 |
DisclosureSEC source: 0001099219-24-000053 · wk-form4_1709241616.xml · nonDerivative · entry 3 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,389 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantCommon Stock | 7,577 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000053 · wk-form4_1709241616.xml · nonDerivative · entry 2 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,640 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
SCHOCK TAMARAEVP & Chief Accounting Officer
|
GrantCommon Stock | 2,531 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000053 · wk-form4_1709241616.xml · nonDerivative · entry 1 SCHOCK TAMARA · CIK 0001761331 · EVP & Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,063 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantEmployee Stock Options (right to buy) · Derivative | 27,983 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000052 · wk-form4_1709241595.xml · derivative · entry 6 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,983 Underlying: Common Stock · 27,983 shares Expires 2034-02-26 F5 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
Tax withholdingCommon Stock | 29,959 | $69.16 | $2,071,964.44 |
DisclosureSEC source: 0001099219-24-000052 · wk-form4_1709241595.xml · nonDerivative · entry 3 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,201 F4 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantCommon Stock | 62,924 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000052 · wk-form4_1709241595.xml · nonDerivative · entry 2 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,160 F3 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance shares under the MetLife, Inc. 2015 Stock and Incentive Compensation. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:20 UTC |
PAPPAS BILLEVP, Global Tech. & Ops.
|
GrantCommon Stock | 9,327 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000052 · wk-form4_1709241595.xml · nonDerivative · entry 1 PAPPAS BILL · CIK 0001787586 · EVP, Global Tech. & Ops. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,236 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. F2 · balance_after: On November 15, 2023, 7,400 shares were distributed to the reporting person in accordance with the terms of the 2022 GRAT, and are now reported as directly owned. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:19 UTC |
Khalaf MichelDirector · President & CEO
|
GrantEmployee Stock Options (right to buy) · Derivative | 97,614 | $0.00 Strike: $69.16 | $0.00 |
DisclosureSEC source: 0001099219-24-000051 · wk-form4_1709241574.xml · derivative · entry 4 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,614 Underlying: Common Stock · 97,614 shares Expires 2034-02-26 F4 · derivative.exercise_date: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:19 UTC |
Khalaf MichelDirector · President & CEO
|
Tax withholdingCommon Stock | 113,305 | $69.16 | $7,836,173.80 |
DisclosureSEC source: 0001099219-24-000051 · wk-form4_1709241574.xml · nonDerivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 511,968 F3 · kind: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:19 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 206,752 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000051 · wk-form4_1709241574.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,273 F2 · price: Shares acquired from the determination of the performance factor for and payout of 2021-2023 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:19 UTC |
Khalaf MichelDirector · President & CEO
|
GrantCommon Stock | 32,534 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001099219-24-000051 · wk-form4_1709241574.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,521 F1 · price: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:24 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,181 | $0.00 Strike: $45.15 | $0.00 |
DisclosureSEC source: 0001099219-24-000030 · wk-form4_1707341033.xml · derivative · entry 3 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,181 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 2,685 stock options previously added to the reporting person's award through an adjustment to maintain the intrinsic value of the stock options in light of the distribution by MetLife, Inc. to its shareholders of Brighthouse Financial, Inc. common stock. The reporting person did not receive shares of Brighthouse Financial, Inc. common stock on account of the stock options. F4 · derivative.exercise_date: The options became exercisable in three substantially equal installments on February 25, 2015, 2016 and 2017. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:24 UTC |
Khalaf MichelDirector · President & CEO
|
SaleCommon Stock | 20,460 | $65.95 | $1,349,328.82 |
DisclosureSEC source: 0001099219-24-000030 · wk-form4_1707341033.xml · nonDerivative · entry 2 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,987 F1 · shares: The reporting person sold only the number of shares of MetLife, Inc.'s common stock necessary to pay the exercise price of the options exercised on February 5, 2024 and related tax obligations and fees. F2 · price: The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $65.94 to $65.97, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 21:24 UTC |
Khalaf MichelDirector · President & CEO
|
Exercise / conversionCommon Stock | 25,181 | $45.15 | $1,136,922.15 |
DisclosureSEC source: 0001099219-24-000030 · wk-form4_1707341033.xml · nonDerivative · entry 1 Khalaf Michel · CIK 0001535491 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:41 UTC |
Johnson Jeh C.Director
|
GrantCommon Stock | 650 | $67.35 | $43,777.50 |
DisclosureSEC source: 0001099219-24-000026 · wk-form4_1704404486.xml · nonDerivative · entry 1 Johnson Jeh C. · CIK 0001707516 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,195 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:41 UTC |
Kennard William EDirector
|
GrantCommon Stock | 650 | $67.35 | $43,777.50 |
DisclosureSEC source: 0001099219-24-000025 · wk-form4_1704404427.xml · nonDerivative · entry 1 Kennard William E · CIK 0001198236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,463 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:40 UTC |
MCKENZIE DIANADirector
|
GrantCommon Stock | 650 | $67.35 | $43,777.50 |
DisclosureSEC source: 0001099219-24-000024 · wk-form4_1704404290.xml · nonDerivative · entry 1 MCKENZIE DIANA · CIK 0001754648 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,828 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:38 UTC |
HUBBARD ROBERT GLENNDirector
|
GrantCommon Stock | 1,114 | $67.35 | $75,027.90 |
DisclosureSEC source: 0001099219-24-000023 · wk-form4_1704404271.xml · nonDerivative · entry 1 HUBBARD ROBERT GLENN · CIK 0001283051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,922 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees and Board Chair retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:37 UTC |
Herzog David LDirector
|
GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000022 · wk-form4_1704404244.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,412 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:37 UTC |
GUTIERREZ CARLOS MDirector
|
GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000021 · wk-form4_1704404222.xml · nonDerivative · entry 1 GUTIERREZ CARLOS M · CIK 0001185943 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,458 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:36 UTC |
WEINBERGER MARK ADirector
|
GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000020 · wk-form4_1704404205.xml · nonDerivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,514 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:36 UTC |
Kinney Catherine RDirector
|
GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000019 · wk-form4_1704404174.xml · nonDerivative · entry 1 Kinney Catherine R · CIK 0001205054 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,668 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:36 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001099219-24-000018 · wk-form4_1704404157.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,424 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.